GE HealthCare Technologies Inc. (NASDAQ:GEHC) — Market Cap & Net Worth
Market Cap & Net Worth: GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (NASDAQ:GEHC) has a market capitalization of $28.87 Billion ($28.87 Billion) as of June 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #929 globally and #400 in its home market, demonstrating a 0.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GE HealthCare Technologies Inc.'s stock price $64.76 by its total outstanding shares 454891786 (454.89 Million). Review GE HealthCare Technologies Inc. debt and liabilities to assess the company's total debt and financial obligations.
GE HealthCare Technologies Inc. Market Cap History: 2022 to 2026
GE HealthCare Technologies Inc.'s market capitalization history from 2022 to 2026. Data shows growth from $26.49 Billion to $29.46 Billion (2.28% CAGR).
Index Memberships
GE HealthCare Technologies Inc. is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.29 Trillion | 0.06% | #293 of 503 |
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 1.18% | #12 of 976 |
|
NASDAQ Composite
IXIC
|
$41.39 Trillion | 0.07% | #117 of 3165 |
|
Nasdaq 100
NDX
|
$34.66 Trillion | 0.08% | #86 of 101 |
Weight: GE HealthCare Technologies Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GE HealthCare Technologies Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GE HealthCare Technologies Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.81x
GE HealthCare Technologies Inc.'s market cap is 1.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.90x
GE HealthCare Technologies Inc.'s market cap is 17.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $26.49 Billion | $18.34 Billion | $1.92 Billion | 1.44x | 13.82x |
| 2023 | $35.12 Billion | $19.55 Billion | $3.10 Billion | 1.80x | 11.31x |
| 2024 | $35.75 Billion | $19.67 Billion | $1.99 Billion | 1.82x | 17.94x |
| 2025 | $37.31 Billion | $20.62 Billion | $2.08 Billion | 1.81x | 17.90x |
Competitor Companies of GEHC by Market Capitalization
Companies near GE HealthCare Technologies Inc. in the global market cap rankings as of June 16, 2026.
Key companies related to GE HealthCare Technologies Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $154.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.85 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #245 globally with a market cap of $103.20 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $154.19 Billion | $88.67 |
| #205 | Stryker Corporation | NYSE:SYK | $117.85 Billion | $307.94 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | NYSE:MDT | $103.20 Billion | $80.38 |
GE HealthCare Technologies Inc. Historical Marketcap From 2022 to 2026
Between 2022 and today, GE HealthCare Technologies Inc.'s market cap moved from $26.49 Billion to $ 29.46 Billion, with a yearly change of 2.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $29.46 Billion | -21.04% |
| 2025 | $37.31 Billion | +4.35% |
| 2024 | $35.75 Billion | +1.80% |
| 2023 | $35.12 Billion | +32.60% |
| 2022 | $26.49 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of GE HealthCare Technologies Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.87 Billion USD |
| MoneyControl | $28.87 Billion USD |
| MarketWatch | $28.87 Billion USD |
| marketcap.company | $28.87 Billion USD |
| Reuters | $28.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more